Equities Analysts Set Expectations for ACAD FY2025 Earnings
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Stock analysts at HC Wainwright reduced their FY2025 EPS estimates for ACADIA Pharmaceuticals in a research note issued on Thursday, February 27th. HC Wainwright analyst A. Fein now anticipates that the biopharmaceutical company will post earnings per share of $0.70 for the year, down from their previous […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Stock analysts at HC Wainwright reduced their FY2025 EPS estimates for ACADIA Pharmaceuticals in a research note issued on Thursday, February 27th. HC Wainwright analyst A. Fein now anticipates that the biopharmaceutical company will post earnings per share of $0.70 for the year, down from their previous […]
